Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery
- 1 September 2012
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 66 (3) , 251-259
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunctionTrends in Pharmacological Sciences, 2012
- Endocannabinoids and cardiac contractile function: Pathophysiological implicationsPharmacological Research, 2009
- Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aortaBritish Journal of Pharmacology, 2007
- Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsBritish Journal of Pharmacology, 2007
- Evidence for novel cannabinoid receptorsPharmacology & Therapeutics, 2005
- Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteriesBritish Journal of Pharmacology, 2004
- The complexities of the cardiovascular actions of cannabinoidsBritish Journal of Pharmacology, 2004
- Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid ReceptorMolecular Pharmacology, 2003
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptorsProceedings of the National Academy of Sciences, 1999
- Mesenteric Vasodilation Mediated by Endothelial Anandamide ReceptorsHypertension, 1999